🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

505 results for “Oral” Clear

  1. Placebo: PL1, Pharmaceutical form: Capsule, Route of administration: Oral use, Hydrocortison DMB 20 mg, tabletten

    Disc Medicine

    Posttraumatic Stress Disorder (PTSD)

    approved small molecule active

    1 trial

  2. RO7034067, Evrysdi 0.75 mg/mL powder for oral solution

    Hoffmann-La Roche

    Spinal Muscular Atrophy (SMA)

    approved small molecule active

    1 trial

  3. Rifaximin Oral Tablet

    Hospital Authority, Hong Kong

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule completed

    1 trial

  4. Rivaroxaban 2.5 MG Oral Tablet [Xarelto]

    The University of Hong Kong

    Atherosclerosis, Coronary

    approved small molecule completed

    1 trial

  5. SALINE, TRANEXAMIC ACID

    Disc Medicine

    Slipped capital femoral epiphysis (SCFE), Legg-Calvé-Perthes Disease (LCPD), Neuromuscular conditions, Secondary hip dysplasia, Developmental dysplasia of the hip (DDH)

    approved small molecule active

    1 trial

  6. Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

    Sanofi Pasteur

    Cholera

    approved mab completed

    1 trial

  7. Shenlingcao Oral Liquid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  8. Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]

    BRIGHT MINDS BIOSCIENCES INC.

    HEPATITIS C (HCV)

    approved small molecule active

    1 trial

  9. Solriamfetol Oral Tablet

    Axsome Therapeutics

    Excessive Sleepiness

    approved small molecule terminated

    1 trial

  10. TILMANOCEPT, TILMANOCEPT, GALLIUM (68GA) CHLORIDE, TECHNETIUM (99MTC)

    Disc Medicine

    Oral cancer

    approved small molecule active

    1 trial

  11. Tamsulosin Oral Capsule

    The First People's Hospital of Lianyungang

    Ischaemic Heart Disease (IHD)

    approved small molecule completed

    1 trial

  12. Tenofovir Alafenamide fumarate 25mg Oral Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  13. VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg

    Pfizer Australia Pty Ltd

    Migraine attacks with or without aura

    approved small molecule active

    1 trial

  14. Valbenazine Oral Capsule

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia

    approved small molecule terminated

    1 trial

  15. Zaredrop 75 mg/ml soluzione orale, Laroxyl 40 mg/ml gocce orali soluzione, FLUOXETINA DOC Generici 20 mg/5 ml Soluzione orale, Zoloft 20 mg/ml concentrato per soluzione orale, Brintellix 20 mg/ml oral drops, solution, Daparox 33,1 mg/ml, gocce orali, soluzione., CITALOPRAM ABC 40 mg/ml gocce orali, soluzione, ESCITALOPRAM DOC 20 mg/ml gocce orali, soluzione

    Verona Pharma Ireland Limited

    Patients with currently remitted depressive disorders.

    approved small molecule active

    1 trial

  16. glatiramer acetate injection with oral cetirizine hydrochloride

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  17. oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  18. Alcohol(oral) and placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Drinking

    small molecule completed

    1 trial

  19. Atorvastatin 20 Mg Oral Tablet

    The First People's Hospital of Lianyungang

    Atherosclerotic Cardiovascular Disease

    small molecule active

    1 trial

  20. Avatrombopag 20 MG Oral Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aplastic Anemia

    small molecule active

    1 trial

  21. Bactoblis

    The First People's Hospital of Lianyungang

    Oral Disease

    other completed

    1 trial

  22. Cognitive behavioral therapy for anxiety plus benzodiazepine taper

    BRIGHT MINDS BIOSCIENCES INC.

    Anxiety Disorders

    other completed

    1 trial

  23. Eefooton oral solution

    Hospital Authority, Hong Kong

    Chronic Kidney Diseases

    other completed

    1 trial

  24. Escitalopram (Oral antidepressant)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depression - Major Depressive Disorder

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources